Neurostimulation

Josh Sandberg June 22, 2020

1,555

Mainstay Medical Announces U.S. FDA Approval of ReActiv8® Neurostimulation System for Chronic Low Back Pain

June 22, 2020 DUBLIN–(BUSINESS WIRE)–Mainstay Medical Holdings plc (“Mainstay” or the “Company”) today announced that the U.S. Food and Drug…

SurGenTec® Announces FDA Clearance for Neurostimulation with ALARA™ Access Needle Kit

August 22, 2019 BOCA RATON, Fla.–(BUSINESS WIRE)–SurGenTec, a privately held spine and orthopedic technology company, announced today it has received…

Spinal Intervention: Markets for Surgical, Replacement & Neurostimulation Technologies – Research and Markets

December 16, 2016 DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Spinal Intervention: Markets for Surgical, Replacement and…